Prospective antimicrobial audit and feedback did not decrease case fatality: Experiences from a hospital in northern Taiwan
Author(s) -
ChienYu Cheng,
Chien-Yu Lee,
Min-Wen Wu,
Chen-Hung Chang,
Wanying Huang,
Yi-Fen Chuang,
Pei-Hsin Tang,
ShuHsing Cheng
Publication year - 2016
Publication title -
the journal of infection in developing countries
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 49
eISSN - 2036-6590
pISSN - 1972-2680
DOI - 10.3855/jidc.6891
Subject(s) - medicine , cilastatin , meropenem , tazobactam , antimicrobial stewardship , piperacillin , linezolid , cefepime , tigecycline , ertapenem , prospective cohort study , levofloxacin , antimicrobial , imipenem , vancomycin , intensive care medicine , antibiotics , antibiotic resistance , staphylococcus aureus , microbiology and biotechnology , genetics , bacteria , pseudomonas aeruginosa , biology
Although a prospective antimicrobial audit and feedback is an effective strategy in an antibiotic stewardship program, previous researchers have not adequately demonstrated a successful impact on patient outcomes. In this study, the causes of fatalities associated with a prospective antimicrobial audit and feedback were analyzed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom